ES2537905B2 - Uso de 12- desoxiforboles para promover la proliferación de las células madre neurales - Google Patents
Uso de 12- desoxiforboles para promover la proliferación de las células madre neurales Download PDFInfo
- Publication number
- ES2537905B2 ES2537905B2 ES201301153A ES201301153A ES2537905B2 ES 2537905 B2 ES2537905 B2 ES 2537905B2 ES 201301153 A ES201301153 A ES 201301153A ES 201301153 A ES201301153 A ES 201301153A ES 2537905 B2 ES2537905 B2 ES 2537905B2
- Authority
- ES
- Spain
- Prior art keywords
- proliferation
- stem cells
- neural stem
- promote
- deoxiforboles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Uso de 12-desoxiforboles para promover la proliferación de células madre neurales.#Esta invención está relacionada con el empleo de compuestos de la familia 12-desoxiforboles o una sal farmacológicamente activa de dichos compuestos, para favorecer la proliferación de precursores neurales o células madre neurales en cultivo. Adicionalmente, también se relaciona con el empleo de esta familia de compuestos para la elaboración de una composición farmacéutica útil en el tratamiento de enfermedades del sistema nervioso central que cursen con perdida neuronal.
Description
Claims (1)
-
imagen1 imagen2 imagen3 imagen4 imagen5 imagen6 imagen7
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201301153A ES2537905B2 (es) | 2013-12-11 | 2013-12-11 | Uso de 12- desoxiforboles para promover la proliferación de las células madre neurales |
PCT/ES2014/000180 WO2015086866A1 (es) | 2013-12-11 | 2014-10-24 | Uso de 12-desoxiforboles para promover la expansión de células madre neurales |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES201301153A ES2537905B2 (es) | 2013-12-11 | 2013-12-11 | Uso de 12- desoxiforboles para promover la proliferación de las células madre neurales |
Publications (3)
Publication Number | Publication Date |
---|---|
ES2537905A2 ES2537905A2 (es) | 2015-06-15 |
ES2537905R2 ES2537905R2 (es) | 2015-06-29 |
ES2537905B2 true ES2537905B2 (es) | 2015-10-14 |
Family
ID=53290863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES201301153A Active ES2537905B2 (es) | 2013-12-11 | 2013-12-11 | Uso de 12- desoxiforboles para promover la proliferación de las células madre neurales |
Country Status (2)
Country | Link |
---|---|
ES (1) | ES2537905B2 (es) |
WO (1) | WO2015086866A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2916383B2 (es) * | 2020-12-29 | 2023-12-13 | Univ Cadiz | Derivados de 12-desoxiforboles y usos de los mismos |
-
2013
- 2013-12-11 ES ES201301153A patent/ES2537905B2/es active Active
-
2014
- 2014-10-24 WO PCT/ES2014/000180 patent/WO2015086866A1/es active Application Filing
Also Published As
Publication number | Publication date |
---|---|
ES2537905R2 (es) | 2015-06-29 |
ES2537905A2 (es) | 2015-06-15 |
WO2015086866A1 (es) | 2015-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123460T1 (el) | Ενωσεις και μεθοδοι για τη θεραπεια μιας επιληπτικης διαταραχης | |
CL2016001895A1 (es) | Compuestos | |
BR112016015838A8 (pt) | compostos heterocíclicos aromáticos, composição farmacêutica compreendendo os referidos compostos e produto de combinação | |
CR20150628A (es) | Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades | |
DOP2015000274A (es) | Compuestos químicos | |
CL2015003690A1 (es) | Uso de pridopidina o una sal de la misma para preparar un medicamento útil en el tratamiento de la enfermedad de huntington. | |
CR20160222U (es) | Formas solidas de acido { [ -(3- clorofenil) -3- hidroxipiridin -2-carbonil] amino} acetico, composiciones, y usos de las mismas | |
ECSP14013284A (es) | Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas | |
AR093490A1 (es) | Formas de dosificacion de ruxolitinib de liberacion sostenida | |
CO6791571A2 (es) | Moduladores de la proteína tirosina quinasa 7 (ptk7) para el tratamiento diagnóstico o profilaxis de trastornos neoplásicos | |
CL2014001547A1 (es) | Compuestos derivados de benzotienilo-pirrolotriazina, como inhibidores de la proteina tirosina quinasa; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para el tratamiento y/o la prevencion de cancer y enfermedades tumorales. | |
ECSP20046463A (es) | Compuestos, composiciones y métodos para tratar enfermedades que involucren tejidos con enfermedades ácidas o hipóxicas | |
CL2013003372A1 (es) | Compuestos derivados de espiro-[1,3]-oxacinas y espiro-[1,4]-oxacepinas, inhibidores de bace1 y/o bace2; composicion farmaceutica; procedimiento para prepararlos; y su uso en el tratamiento y/o la profilaxis de la enfermedad de alzheimer y diabetes. | |
CL2019002900A1 (es) | Análogos de benzoazepina como agentes inhibidores de la tirosina cinasa de bruton. | |
CL2016002510A1 (es) | 2-amino-6-metil-4,4a,5,6-tetrahidropirano [3,4-d][1,3] tiazin-8a(8h)-il-1,3-tiazol-4-ilamidas. | |
NI201600160A (es) | Compuestos heteroaromáticos y su uso como ligandos de dopamina d1 | |
BR112016020260A8 (pt) | uso de um composto na fabricação de um medicamento para tratar uma doença colestática intra-hepática | |
AR104755A1 (es) | Método para el tratamiento de enfermedad neurológica | |
GT201700016A (es) | [1,2,4] triazolo [4,3 -b] piridazinas para su uso en el tratamiento de enfermedades proliferativas | |
BR112015029894A2 (pt) | forma de dosagem farmacêutica sólida | |
BR112019004236A2 (pt) | compostos para tratar doenças associadas a uma disfunção mitocondrial | |
NI201600161A (es) | Compuestos heteroaromáticos y su uso como ligandos de dopamina d1 | |
CL2017000117A1 (es) | Dihidropirimidinonas bicíclicas sustituidas y su uso como inhibidores de la actividad de elastasa neutrófila. | |
BR112017021583A2 (pt) | métodos para o tratamento de transtornos inflamatórios | |
ES2537905B2 (es) | Uso de 12- desoxiforboles para promover la proliferación de las células madre neurales |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 2537905 Country of ref document: ES Kind code of ref document: B2 Effective date: 20151014 |